Processa Pharmaceuticals, Inc.
USD1.93
-0.01 (-0.52%)
CEO
George K. Ng
IPO Date
2014-03-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.90
Prev. Close
$1.94
Day Low
$1.87
Day High
$2.02
52W Low
$1.76
52W High
$14.25
Market Cap
$0.00B
Volume
0.03M
| -0.2 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -222.9% | -192.2% | 0.03 | 7.71 | -0.8 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -367.1% | -318.2% | 0.03 | 8.40 | -0.6 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -44.8% | -43.2% | 0.00 | 18.87 | -6.6 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -83.0% | -75.5% | 0.01 | 13.27 | -2.6 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -41.9% | -30.9% | 0.13 | 0.85 | -29.6 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -38.8% | -28.5% | 0.02 | 3.13 | -35.7 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -497.5% | -62.2% | 6.56 | 1.14 | -77.3 |
| 31 Dec 2016 | FY | 72.4% | -6719.6% | 14.3% | -10379.4% | -0.69 | 0.03 | -3.1 |
| -0.6 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -58.9% | -45.3% | 0.00 | 3.76 | -0.7 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -64.4% | -48.1% | 0.00 | 3.45 | -0.2 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -80.4% | -58.9% | 0.01 | 2.93 | -0.3 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -160.9% | -84.5% | 0.04 | 1.22 | -0.3 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -91.0% | -68.5% | 0.03 | 3.97 | -0.3 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -50.0% | -39.6% | 0.02 | 4.82 | -0.5 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -30.7% | -27.4% | 0.02 | 9.70 | -0.5 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -48.2% | -41.6% | 0.03 | 7.71 | -0.9 |